Board Rejects Challenge Of Blood Clotting Protein Patent In Final Decision

Mealey's (April 8, 2018, 10:35 PM EDT) -- ALEXANDRIA, Va. — Allegations that a claimed method for improving the viral safety of liquid compositions comprising “Factor VII” (FVII) — a protein involved in the blood clotting process — is...
To view the full article, register now.